{
    "Trade/Device Name(s)": [
        "SeraQuest HSV Type 2 Specific IgG",
        "SeraQuest\u00ae HSV Type 2 Specific IgG"
    ],
    "Submitter Information": "Quest International, Inc.",
    "510(k) Number": "K181514",
    "Predicate Device Reference 510(k) Number(s)": [
        "K152353"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYF"
    ],
    "Summary Letter Date": "May 13, 2019",
    "Summary Letter Received Date": "May 15, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays"
    ],
    "Analyte Class(es)": [
        "immunology",
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Herpes Simplex Virus Type 2 (HSV-2)"
    ],
    "Specimen Type(s)": [
        "Human serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "ChemWell\u00ae Automated Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Enzyme immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "ELISA"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for SeraQuest HSV Type 2 Specific IgG ELISA assay for qualitative detection of human IgG antibodies to HSV-2 in serum using ChemWell Automated Analyzer.",
    "Indications for Use Summary": "Qualitative detection of human IgG antibodies to HSV-2 in human serum for sexually active individuals and expectant mothers as an aid in presumptive diagnosis of HSV-2 infection; not cleared for blood/plasma donor screening or for immunocompromised, pediatric patients, or matrices other than human serum.",
    "fda_folder": "Microbiology"
}